Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Coagulation Factor Concentrates Market Research Report 2019-2025

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Coagulation Factor Concentrates Product Introduction
  • 1.2 Market Segments
  • 1.3 Key Coagulation Factor Concentrates Manufacturers Covered: Ranking by Revenue
  • 1.4 Market by Type
    • 1.4.1 Global Coagulation Factor Concentrates Market Size Growth Rate by Type
    • 1.4.2 Factor VIII
    • 1.4.3 Factor IX
    • 1.4.4 Von Willebrand Factor
    • 1.4.5 Prothrombin Complex Concentrates
    • 1.4.6 Fibrinogen Concentrates
    • 1.4.7 Factor XIII
  • 1.5 Market by Application
    • 1.5.1 Global Coagulation Factor Concentrates Market Size Growth Rate by Application
    • 1.5.2 Neurology
    • 1.5.3 Immunology
    • 1.5.4 Hematology
    • 1.5.5 Critical Care
    • 1.5.6 Pulmonology
    • 1.5.7 Hemato-Oncology
    • 1.5.8 Rheumatology
    • 1.5.9 Others
  • 1.6 Study Objectives
  • 1.7 Years Considered

2 Executive Summary

  • 2.1 Global Coagulation Factor Concentrates Market Size, Estimates and Forecasts
    • 2.1.1 Global Coagulation Factor Concentrates Revenue 2015-2026
    • 2.1.2 Global Coagulation Factor Concentrates Sales 2015-2026
  • 2.2 Global Coagulation Factor Concentrates, Market Size by Producing Regions: 2015 VS 2020 VS 2026
    • 2.2.1 Global Coagulation Factor Concentrates Retrospective Market Scenario in Sales by Region: 2015-2020
    • 2.2.2 Global Coagulation Factor Concentrates Retrospective Market Scenario in Revenue by Region: 2015-2020

3 Global Coagulation Factor Concentrates Competitor Landscape by Players

  • 3.1 Coagulation Factor Concentrates Sales by Manufacturers
    • 3.1.1 Coagulation Factor Concentrates Sales by Manufacturers (2015-2020)
    • 3.1.2 Coagulation Factor Concentrates Sales Market Share by Manufacturers (2015-2020)
  • 3.2 Coagulation Factor Concentrates Revenue by Manufacturers
    • 3.2.1 Coagulation Factor Concentrates Revenue by Manufacturers (2015-2020)
    • 3.2.2 Coagulation Factor Concentrates Revenue Share by Manufacturers (2015-2020)
    • 3.2.3 Global Coagulation Factor Concentrates Market Concentration Ratio (CR5 and HHI) (2015-2020)
    • 3.2.4 Global Top 10 and Top 5 Companies by Coagulation Factor Concentrates Revenue in 2019
    • 3.2.5 Global Coagulation Factor Concentrates Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 3.3 Coagulation Factor Concentrates Price by Manufacturers
  • 3.4 Coagulation Factor Concentrates Manufacturing Base Distribution, Product Types
    • 3.4.1 Coagulation Factor Concentrates Manufacturers Manufacturing Base Distribution, Headquarters
    • 3.4.2 Manufacturers Coagulation Factor Concentrates Product Type
    • 3.4.3 Date of International Manufacturers Enter into Coagulation Factor Concentrates Market
  • 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Market Size by Type (2015-2026)

  • 4.1 Global Coagulation Factor Concentrates Market Size by Type (2015-2020)
    • 4.1.1 Global Coagulation Factor Concentrates Sales by Type (2015-2020)
    • 4.1.2 Global Coagulation Factor Concentrates Revenue by Type (2015-2020)
    • 4.1.3 Coagulation Factor Concentrates Average Selling Price (ASP) by Type (2015-2026)
  • 4.2 Global Coagulation Factor Concentrates Market Size Forecast by Type (2021-2026)
    • 4.2.1 Global Coagulation Factor Concentrates Sales Forecast by Type (2021-2026)
    • 4.2.2 Global Coagulation Factor Concentrates Revenue Forecast by Type (2021-2026)
    • 4.2.3 Coagulation Factor Concentrates Average Selling Price (ASP) Forecast by Type (2021-2026)
  • 4.3 Global Coagulation Factor Concentrates Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End

5 Market Size by Application (2015-2026)

  • 5.1 Global Coagulation Factor Concentrates Market Size by Application (2015-2020)
    • 5.1.1 Global Coagulation Factor Concentrates Sales by Application (2015-2020)
    • 5.1.2 Global Coagulation Factor Concentrates Revenue by Application (2015-2020)
    • 5.1.3 Coagulation Factor Concentrates Price by Application (2015-2020)
  • 5.2 Coagulation Factor Concentrates Market Size Forecast by Application (2021-2026)
    • 5.2.1 Global Coagulation Factor Concentrates Sales Forecast by Application (2021-2026)
    • 5.2.2 Global Coagulation Factor Concentrates Revenue Forecast by Application (2021-2026)
    • 5.2.3 Global Coagulation Factor Concentrates Price Forecast by Application (2021-2026)

6 North America

  • 6.1 North America Coagulation Factor Concentrates by Country
    • 6.1.1 North America Coagulation Factor Concentrates Sales by Country
    • 6.1.2 North America Coagulation Factor Concentrates Revenue by Country
    • 6.1.3 U.S.
    • 6.1.4 Canada
  • 6.2 North America Coagulation Factor Concentrates Market Facts & Figures by Type
  • 6.3 North America Coagulation Factor Concentrates Market Facts & Figures by Application

7 Europe

  • 7.1 Europe Coagulation Factor Concentrates by Country
    • 7.1.1 Europe Coagulation Factor Concentrates Sales by Country
    • 7.1.2 Europe Coagulation Factor Concentrates Revenue by Country
    • 7.1.3 Germany
    • 7.1.4 France
    • 7.1.5 U.K.
    • 7.1.6 Italy
    • 7.1.7 Russia
  • 7.2 Europe Coagulation Factor Concentrates Market Facts & Figures by Type
  • 7.3 Europe Coagulation Factor Concentrates Market Facts & Figures by Application

8 Asia Pacific

  • 8.1 Asia Pacific Coagulation Factor Concentrates by Region
    • 8.1.1 Asia Pacific Coagulation Factor Concentrates Sales by Region
    • 8.1.2 Asia Pacific Coagulation Factor Concentrates Revenue by Region
    • 8.1.3 China
    • 8.1.4 Japan
    • 8.1.5 South Korea
    • 8.1.6 India
    • 8.1.7 Australia
    • 8.1.8 Taiwan
    • 8.1.9 Indonesia
    • 8.1.10 Thailand
    • 8.1.11 Malaysia
    • 8.1.12 Philippines
    • 8.1.13 Vietnam
  • 8.2 Asia Pacific Coagulation Factor Concentrates Market Facts & Figures by Type
  • 8.3 Asia Pacific Coagulation Factor Concentrates Market Facts & Figures by Application

9 Latin America

  • 9.1 Latin America Coagulation Factor Concentrates by Country
    • 9.1.1 Latin America Coagulation Factor Concentrates Sales by Country
    • 9.1.2 Latin America Coagulation Factor Concentrates Revenue by Country
    • 9.1.3 Mexico
    • 9.1.4 Brazil
    • 9.1.5 Argentina
  • 9.2 Central & South America Coagulation Factor Concentrates Market Facts & Figures by Type
  • 9.3 Central & South America Coagulation Factor Concentrates Market Facts & Figures by Application

10 Middle East and Africa

  • 10.1 Middle East and Africa Coagulation Factor Concentrates by Country
    • 10.1.1 Middle East and Africa Coagulation Factor Concentrates Sales by Country
    • 10.1.2 Middle East and Africa Coagulation Factor Concentrates Revenue by Country
    • 10.1.3 Turkey
    • 10.1.4 Saudi Arabia
    • 10.1.5 U.A.E
  • 10.2 Middle East and Africa Coagulation Factor Concentrates Market Facts & Figures by Type
  • 10.3 Middle East and Africa Coagulation Factor Concentrates Market Facts & Figures by Application

11 Company Profiles

  • 11.1 CSL (Australia)
    • 11.1.1 CSL (Australia) Corporation Information
    • 11.1.2 CSL (Australia) Description and Business Overview
    • 11.1.3 CSL (Australia) Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 CSL (Australia) Coagulation Factor Concentrates Products Offered
    • 11.1.5 CSL (Australia) Related Developments
  • 11.2 Grifols (Spain)
    • 11.2.1 Grifols (Spain) Corporation Information
    • 11.2.2 Grifols (Spain) Description and Business Overview
    • 11.2.3 Grifols (Spain) Sales, Revenue and Gross Margin (2015-2020)
    • 11.2.4 Grifols (Spain) Coagulation Factor Concentrates Products Offered
    • 11.2.5 Grifols (Spain) Related Developments
  • 11.3 Shire (Ireland)
    • 11.3.1 Shire (Ireland) Corporation Information
    • 11.3.2 Shire (Ireland) Description and Business Overview
    • 11.3.3 Shire (Ireland) Sales, Revenue and Gross Margin (2015-2020)
    • 11.3.4 Shire (Ireland) Coagulation Factor Concentrates Products Offered
    • 11.3.5 Shire (Ireland) Related Developments
  • 11.4 Octapharma (Switzerland)
    • 11.4.1 Octapharma (Switzerland) Corporation Information
    • 11.4.2 Octapharma (Switzerland) Description and Business Overview
    • 11.4.3 Octapharma (Switzerland) Sales, Revenue and Gross Margin (2015-2020)
    • 11.4.4 Octapharma (Switzerland) Coagulation Factor Concentrates Products Offered
    • 11.4.5 Octapharma (Switzerland) Related Developments
  • 11.5 Kedrion (Italy)
    • 11.5.1 Kedrion (Italy) Corporation Information
    • 11.5.2 Kedrion (Italy) Description and Business Overview
    • 11.5.3 Kedrion (Italy) Sales, Revenue and Gross Margin (2015-2020)
    • 11.5.4 Kedrion (Italy) Coagulation Factor Concentrates Products Offered
    • 11.5.5 Kedrion (Italy) Related Developments
  • 11.6 Bio Product Laboratory (UK)
    • 11.6.1 Bio Product Laboratory (UK) Corporation Information
    • 11.6.2 Bio Product Laboratory (UK) Description and Business Overview
    • 11.6.3 Bio Product Laboratory (UK) Sales, Revenue and Gross Margin (2015-2020)
    • 11.6.4 Bio Product Laboratory (UK) Coagulation Factor Concentrates Products Offered
    • 11.6.5 Bio Product Laboratory (UK) Related Developments
  • 11.7 Sanquin (Netherlands)
    • 11.7.1 Sanquin (Netherlands) Corporation Information
    • 11.7.2 Sanquin (Netherlands) Description and Business Overview
    • 11.7.3 Sanquin (Netherlands) Sales, Revenue and Gross Margin (2015-2020)
    • 11.7.4 Sanquin (Netherlands) Coagulation Factor Concentrates Products Offered
    • 11.7.5 Sanquin (Netherlands) Related Developments
  • 11.8 LFB (France)
    • 11.8.1 LFB (France) Corporation Information
    • 11.8.2 LFB (France) Description and Business Overview
    • 11.8.3 LFB (France) Sales, Revenue and Gross Margin (2015-2020)
    • 11.8.4 LFB (France) Coagulation Factor Concentrates Products Offered
    • 11.8.5 LFB (France) Related Developments
  • 11.9 Biotest (Germany)
    • 11.9.1 Biotest (Germany) Corporation Information
    • 11.9.2 Biotest (Germany) Description and Business Overview
    • 11.9.3 Biotest (Germany) Sales, Revenue and Gross Margin (2015-2020)
    • 11.9.4 Biotest (Germany) Coagulation Factor Concentrates Products Offered
    • 11.9.5 Biotest (Germany) Related Developments
  • 11.10 Japan Blood Products Organization, China Biologic Products (China)
    • 11.10.1 Japan Blood Products Organization, China Biologic Products (China) Corporation Information
    • 11.10.2 Japan Blood Products Organization, China Biologic Products (China) Description and Business Overview
    • 11.10.3 Japan Blood Products Organization, China Biologic Products (China) Sales, Revenue and Gross Margin (2015-2020)
    • 11.10.4 Japan Blood Products Organization, China Biologic Products (China) Coagulation Factor Concentrates Products Offered
    • 11.10.5 Japan Blood Products Organization, China Biologic Products (China) Related Developments
  • 11.1 CSL (Australia)
    • 11.1.1 CSL (Australia) Corporation Information
    • 11.1.2 CSL (Australia) Description and Business Overview
    • 11.1.3 CSL (Australia) Sales, Revenue and Gross Margin (2015-2020)
    • 11.1.4 CSL (Australia) Coagulation Factor Concentrates Products Offered
    • 11.1.5 CSL (Australia) Related Developments
  • 11.12 Shanghai RAAS Blood Products (China)
    • 11.12.1 Shanghai RAAS Blood Products (China) Corporation Information
    • 11.12.2 Shanghai RAAS Blood Products (China) Description and Business Overview
    • 11.12.3 Shanghai RAAS Blood Products (China) Sales, Revenue and Gross Margin (2015-2020)
    • 11.12.4 Shanghai RAAS Blood Products (China) Products Offered
    • 11.12.5 Shanghai RAAS Blood Products (China) Related Developments

12 Future Forecast by Regions (Countries) (2021-2026)

  • 12.1 Coagulation Factor Concentrates Market Estimates and Projections by Region
    • 12.1.1 Global Coagulation Factor Concentrates Sales Forecast by Regions 2021-2026
    • 12.1.2 Global Coagulation Factor Concentrates Revenue Forecast by Regions 2021-2026
  • 12.2 North America Coagulation Factor Concentrates Market Size Forecast (2021-2026)
    • 12.2.1 North America: Coagulation Factor Concentrates Sales Forecast (2021-2026)
    • 12.2.2 North America: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
    • 12.2.3 North America: Coagulation Factor Concentrates Market Size Forecast by Country (2021-2026)
  • 12.3 Europe Coagulation Factor Concentrates Market Size Forecast (2021-2026)
    • 12.3.1 Europe: Coagulation Factor Concentrates Sales Forecast (2021-2026)
    • 12.3.2 Europe: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
    • 12.3.3 Europe: Coagulation Factor Concentrates Market Size Forecast by Country (2021-2026)
  • 12.4 Asia Pacific Coagulation Factor Concentrates Market Size Forecast (2021-2026)
    • 12.4.1 Asia Pacific: Coagulation Factor Concentrates Sales Forecast (2021-2026)
    • 12.4.2 Asia Pacific: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
    • 12.4.3 Asia Pacific: Coagulation Factor Concentrates Market Size Forecast by Region (2021-2026)
  • 12.5 Latin America Coagulation Factor Concentrates Market Size Forecast (2021-2026)
    • 12.5.1 Latin America: Coagulation Factor Concentrates Sales Forecast (2021-2026)
    • 12.5.2 Latin America: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
    • 12.5.3 Latin America: Coagulation Factor Concentrates Market Size Forecast by Country (2021-2026)
  • 12.6 Middle East and Africa Coagulation Factor Concentrates Market Size Forecast (2021-2026)
    • 12.6.1 Middle East and Africa: Coagulation Factor Concentrates Sales Forecast (2021-2026)
    • 12.6.2 Middle East and Africa: Coagulation Factor Concentrates Revenue Forecast (2021-2026)
    • 12.6.3 Middle East and Africa: Coagulation Factor Concentrates Market Size Forecast by Country (2021-2026)

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis

  • 13.1 Market Opportunities and Drivers
  • 13.2 Market Challenges
  • 13.3 Market Risks/Restraints
  • 13.4 Porter's Five Forces Analysis
  • 13.5 Primary Interviews with Key Coagulation Factor Concentrates Players (Opinion Leaders)

14 Value Chain and Sales Channels Analysis

  • 14.1 Value Chain Analysis
  • 14.2 Coagulation Factor Concentrates Customers
  • 14.3 Sales Channels Analysis
    • 14.3.1 Sales Channels
    • 14.3.2 Distributors

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Research Methodology
      • 16.1.1 Methodology/Research Approach
      • 16.1.2 Data Source
    • 16.2 Author Details

    Coagulation Factor Concentrates market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Coagulation Factor Concentrates market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.

    Segment by Type, the Coagulation Factor Concentrates market is segmented into
    Factor VIII
    Factor IX
    Von Willebrand Factor
    Prothrombin Complex Concentrates
    Fibrinogen Concentrates
    Factor XIII

    Segment by Application, the Coagulation Factor Concentrates market is segmented into
    Neurology
    Immunology
    Hematology
    Critical Care
    Pulmonology
    Hemato-Oncology
    Rheumatology
    Others

    Regional and Country-level Analysis
    The Coagulation Factor Concentrates market is analysed and market size information is provided by regions (countries).
    The key regions covered in the Coagulation Factor Concentrates market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
    The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
    Competitive Landscape and Coagulation Factor Concentrates Market Share Analysis
    Coagulation Factor Concentrates market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Coagulation Factor Concentrates business, the date to enter into the Coagulation Factor Concentrates market, Coagulation Factor Concentrates product introduction, recent developments, etc.

    The major vendors covered:
    CSL (Australia)
    Grifols (Spain)
    Shire (Ireland)
    Octapharma (Switzerland)
    Kedrion (Italy)
    Bio Product Laboratory (UK)
    Sanquin (Netherlands)
    LFB (France)
    Biotest (Germany)
    Japan Blood Products Organization, China Biologic Products (China)
    Green Cross Corporation (South Korea)
    Shanghai RAAS Blood Products (China)

    Buy now